Skip to main content
Top
Published in: Heart and Vessels 12/2022

14-06-2022 | Stroke | Original Article

Transcranial Doppler for stratification of high-risk morphology of patent foramen ovale in patients with cryptogenic stroke

Authors: Saori Chino, Yasuhide Mochizuki, Keita Mizuma, Saaya Ichikawa, Haruka Miyazaki, Rumi Hachiya, Eiji Toyosaki, Masashi Ota, Hiroto Fukuoka, Toshiko Yamochi, Kenjiro Ono, Toshiro Shinke

Published in: Heart and Vessels | Issue 12/2022

Login to get access

Abstract

Microbubble testing using transcranial Doppler (TCD) is an important screening tool for diagnosing paradoxical cerebral embolism with high-risk PFO. However, little is known about the association between the microbubble test by TCD and the features of high-risk PFO evaluated by transesophageal echocardiography (TEE). We studied 101 consecutive patients at Showa University, from April 2019 to October 2020, who underwent both TCD and TEE with a sufficient Valsalva maneuver and who were strongly suspected by neurologists as cryptogenic stroke. According to the appearance of microbubbles as high-intensity transient signals (HITS), the TCD grade was stratified into three categories based on the criteria (A: none, no HITS, B: small; 1–10 HITS, and C: large; > 10 HITS, or an uncountable number of HITS). Among patients with RLS through the PFO in TEE, high-risk morphological features of PFO for cerebral embolism were evaluated as follows: (1) tunnel height, (2) tunnel length, (3) total excursion distance of the atrial septum into the right and left atrium, (4) existence of Eustachian valve or Chiari network, (5) angle of PFO from the inferior vena cava, and (6) large shunt (20 or more microbubbles). Of 101 patients (TCD grade; Group A = 49, Group B = 26, Group C = 26), RLS through PFO was detected in 37 patients (grade A = 8, grade B = 6, grade C = 23) by TEE. Among PFO-positive patients, tunnel height, length, total excursion distance into the right and left atria, angle of PFO from the inferior vena cava, and frequency of large shunt in TEE were significantly larger in grade C than in grade A and B (p < 0.05). Additionally, grade C patients had significantly more forms of high-risk PFOs than those in grades A and B when the six features of high-risk PFO were compared. A multivariate logistic regression demonstrated that the tunnel length of PFO and the presence of large shunt in TEE were independently associated with large HITS in TCD (odds ratio: 1.18 and 49.5, 95% confidence interval 1.043–1.337 and 10.05–244.3, p = 0.0086 and p < 0.0001, respectively). In conclusion, the existence of a large HITS detected by TCD may have a screening advantage in predicting the high-risk morphologies of PFO that can cause paradoxical cerebral embolism.
Literature
1.
2.
go back to reference Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, Sacco RL, Connolly SJ (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 13(4):429–438CrossRef Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, Sacco RL, Connolly SJ (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 13(4):429–438CrossRef
3.
go back to reference Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59(1):17–20CrossRef Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59(1):17–20CrossRef
4.
go back to reference Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz RS (2005) Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 46(9):1768–1776CrossRef Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz RS (2005) Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 46(9):1768–1776CrossRef
5.
go back to reference Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318(18):1148–1152CrossRef Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318(18):1148–1152CrossRef
6.
go back to reference Mojadidi MK, Zaman MO, Elgendy IY, Mahmoud AN, Patel NK, Agarwal N, Tobis JM, Meier B (2018) Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol 71(9):1035–1043CrossRef Mojadidi MK, Zaman MO, Elgendy IY, Mahmoud AN, Patel NK, Agarwal N, Tobis JM, Meier B (2018) Cryptogenic stroke and patent foramen ovale. J Am Coll Cardiol 71(9):1035–1043CrossRef
7.
go back to reference Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, Khandheria BK (2004) Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 164(9):950–956CrossRef Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, Khandheria BK (2004) Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 164(9):950–956CrossRef
8.
go back to reference Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA (2013) Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv 6(12):1316–1323CrossRef Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA (2013) Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv 6(12):1316–1323CrossRef
9.
go back to reference Shah R, Nayyar M, Jovin IS, Rashid A, Bondy BR, Fan TM, Flaherty MP, Rao SV (2018) Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis. Ann Intern Med 168(5):335–342CrossRef Shah R, Nayyar M, Jovin IS, Rashid A, Bondy BR, Fan TM, Flaherty MP, Rao SV (2018) Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis. Ann Intern Med 168(5):335–342CrossRef
10.
go back to reference Anzola GP (2004) Transcranial Doppler: Cinderella in the assessment of patent foramen ovale in stroke patients. Stroke 35(6):e137CrossRef Anzola GP (2004) Transcranial Doppler: Cinderella in the assessment of patent foramen ovale in stroke patients. Stroke 35(6):e137CrossRef
11.
go back to reference Nemec JJ, Marwick TH, Lorig RJ, Davison MB, Chimowitz MI, Litowitz H, Salcedo EE (1991) Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. Am J Cardiol 68(15):1498–1502CrossRef Nemec JJ, Marwick TH, Lorig RJ, Davison MB, Chimowitz MI, Litowitz H, Salcedo EE (1991) Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. Am J Cardiol 68(15):1498–1502CrossRef
12.
go back to reference Tobe J, Bogiatzi C, Munoz C, Tamayo A, Spence JD (2016) Transcranial Doppler is complementary to echocardiography for detection and risk stratification of patent foramen ovale. Can J Cardiol 32(8):986.e989-986.e916CrossRef Tobe J, Bogiatzi C, Munoz C, Tamayo A, Spence JD (2016) Transcranial Doppler is complementary to echocardiography for detection and risk stratification of patent foramen ovale. Can J Cardiol 32(8):986.e989-986.e916CrossRef
13.
go back to reference Blersch WK, Draganski BM, Holmer SR, Koch HJ, Schlachetzki F, Bogdahn U, Hölscher T (2002) Transcranial duplex sonography in the detection of patent foramen ovale. Radiology 225(3):693–699CrossRef Blersch WK, Draganski BM, Holmer SR, Koch HJ, Schlachetzki F, Bogdahn U, Hölscher T (2002) Transcranial duplex sonography in the detection of patent foramen ovale. Radiology 225(3):693–699CrossRef
14.
go back to reference Komatsu T, Terasawa Y, Arai A, Sakuta K, Mitsumura H, Iguchi Y (2017) Transcranial color-coded sonography of vertebral artery for diagnosis of right-to-left shunts. J Neurol Sci 376:97–101CrossRef Komatsu T, Terasawa Y, Arai A, Sakuta K, Mitsumura H, Iguchi Y (2017) Transcranial color-coded sonography of vertebral artery for diagnosis of right-to-left shunts. J Neurol Sci 376:97–101CrossRef
15.
go back to reference Seidel G, Kaps M, Gerriets T (1995) Potential and limitations of transcranial color-coded sonography in stroke patients. Stroke 26(11):2061–2066CrossRef Seidel G, Kaps M, Gerriets T (1995) Potential and limitations of transcranial color-coded sonography in stroke patients. Stroke 26(11):2061–2066CrossRef
16.
go back to reference De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31(10):2407–2413CrossRef De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31(10):2407–2413CrossRef
17.
go back to reference Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA, Rodriguez LL, Kapadia SR (2009) Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol 103(1):124–129CrossRef Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA, Rodriguez LL, Kapadia SR (2009) Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol 103(1):124–129CrossRef
18.
go back to reference Nakayama R, Takaya Y, Akagi T, Watanabe N, Ikeda M, Nakagawa K, Toh N, Ito H (2019) Identification of high-risk patent foramen ovale associated with cryptogenic stroke: development of a scoring system. J Am Soc Echocardiogr 32(7):811–816CrossRef Nakayama R, Takaya Y, Akagi T, Watanabe N, Ikeda M, Nakagawa K, Toh N, Ito H (2019) Identification of high-risk patent foramen ovale associated with cryptogenic stroke: development of a scoring system. J Am Soc Echocardiogr 32(7):811–816CrossRef
19.
go back to reference Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Dávalos A (1998) The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke 29(7):1322–1328CrossRef Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Dávalos A (1998) The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke 29(7):1322–1328CrossRef
20.
go back to reference Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81(7):619–625CrossRef Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81(7):619–625CrossRef
21.
go back to reference Aaslid R, Markwalder TM, Nornes H (1982) Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 57(6):769–774CrossRef Aaslid R, Markwalder TM, Nornes H (1982) Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 57(6):769–774CrossRef
22.
go back to reference Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS (2021) 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 52(7):e364–e467CrossRef Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS (2021) 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 52(7):e364–e467CrossRef
23.
go back to reference Bogdahn U, Becker G, Winkler J, Greiner K, Perez J, Meurers B (1990) Transcranial color-coded real-time sonography in adults. Stroke 21(12):1680–1688CrossRef Bogdahn U, Becker G, Winkler J, Greiner K, Perez J, Meurers B (1990) Transcranial color-coded real-time sonography in adults. Stroke 21(12):1680–1688CrossRef
24.
go back to reference Baumgartner RW (2003) Transcranial color duplex sonography in cerebrovascular disease: a systematic review. Cerebrovasc Dis 16(1):4–13CrossRef Baumgartner RW (2003) Transcranial color duplex sonography in cerebrovascular disease: a systematic review. Cerebrovasc Dis 16(1):4–13CrossRef
25.
go back to reference Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chedru F, Guérin F, Bousser MG, de Recondo J (1993) Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age a study using transesophageal echocardiography. Stroke 24(12):1865–1873CrossRef Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chedru F, Guérin F, Bousser MG, de Recondo J (1993) Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age a study using transesophageal echocardiography. Stroke 24(12):1865–1873CrossRef
26.
go back to reference Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345(24):1740–1746CrossRef Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345(24):1740–1746CrossRef
27.
go back to reference Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ (1991) Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 18(5):1223–1229CrossRef Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ (1991) Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 18(5):1223–1229CrossRef
28.
go back to reference Belvis R, Leta RG, Marti-Fabregas J, Cocho D, Carreras F, Pons-Llado G, Marti-Vilalta JL (2006) Almost perfect concordance between simultaneous transcranial Doppler and transesophageal echocardiography in the quantification of right-to-left shunts. J Neuroimaging 16(2):133–138CrossRef Belvis R, Leta RG, Marti-Fabregas J, Cocho D, Carreras F, Pons-Llado G, Marti-Vilalta JL (2006) Almost perfect concordance between simultaneous transcranial Doppler and transesophageal echocardiography in the quantification of right-to-left shunts. J Neuroimaging 16(2):133–138CrossRef
29.
go back to reference Horner S, Ni XS, Weihs W, Harb S, Augustin M, Duft M, Niederkorn K (1997) Simultaneous bilateral contrast transcranial doppler monitoring in patients with intracardiac and intrapulmonary shunts. J Neurol Sci 150(1):49–57CrossRef Horner S, Ni XS, Weihs W, Harb S, Augustin M, Duft M, Niederkorn K (1997) Simultaneous bilateral contrast transcranial doppler monitoring in patients with intracardiac and intrapulmonary shunts. J Neurol Sci 150(1):49–57CrossRef
30.
go back to reference Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guérin P, Piot C, Rossi R, Dubois-Randé JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 377(11):1011–1021CrossRef Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guérin P, Piot C, Rossi R, Dubois-Randé JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 377(11):1011–1021CrossRef
31.
go back to reference Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 377(11):1022–1032CrossRef Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 377(11):1022–1032CrossRef
32.
go back to reference Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 377(11):1033–1042CrossRef Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 377(11):1033–1042CrossRef
Metadata
Title
Transcranial Doppler for stratification of high-risk morphology of patent foramen ovale in patients with cryptogenic stroke
Authors
Saori Chino
Yasuhide Mochizuki
Keita Mizuma
Saaya Ichikawa
Haruka Miyazaki
Rumi Hachiya
Eiji Toyosaki
Masashi Ota
Hiroto Fukuoka
Toshiko Yamochi
Kenjiro Ono
Toshiro Shinke
Publication date
14-06-2022
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 12/2022
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02117-9

Other articles of this Issue 12/2022

Heart and Vessels 12/2022 Go to the issue